Carbonic Anhydrase IX Controls Vulnerability to Ferroptosis in Gefitinib-Resistant Lung Cancer

Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI, such as gefitinib) in lung cancer continues to be a major problem. Recent studies have shown the promise of ferroptosis-inducing therapy in EGFR-TKI resistant cancer, but have not been translated into clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chen, Lu, Xiyi, Liu, Xinyin, Xu, Jiali, Li, Jun, Qu, Tianyu, Dai, Jiali, Guo, Renhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904911/
https://www.ncbi.nlm.nih.gov/pubmed/36760347
http://dx.doi.org/10.1155/2023/1367938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904911/
https://www.ncbi.nlm.nih.gov/pubmed/36760347
http://dx.doi.org/10.1155/2023/1367938

Ejemplares similares